SHARE
Vaccine Adjuvants - Global Market Outlook (2017-2026)

Vaccine Adjuvants - Global Market Outlook (2017-2026)

4.5 (46 reviews)
Published: January 2019 ID: SMRC17944
4.5 (46 reviews)
Published: January 2019 ID: SMRC17944

1 Executive Summary     
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Product Analysis    
 3.7 Application Analysis    
 3.8 End User Analysis    
 3.9 Emerging Markets    
 3.10 Futuristic Market Scenario    
      
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Vaccine Adjuvants Market, By Product     
 5.1 Introduction    
 5.2 Pathogen Components     
 5.3 Particulate Adjuvants     
 5.4 Combination Adjuvants     
 5.5 Adjuvant Emulsions     
 5.6 Saponin    
 5.7 Other Types    
      
6 Global Vaccine Adjuvants Market, By Disease Type     
 6.1 Introduction    
 6.2 Cancer    
 6.3 Infectious Diseases    
 6.4 Other Disease Types    
      
7 Global Vaccine Adjuvants Market, By Type     
 7.1 Introduction    
 7.2 Virus-like Particles    
 7.3 Tensoactive Adjuvants          
 7.4 Organic Adjuvants     
 7.5 Mineral Salt based Adjuvants       
 7.6 Liposomes                 
 7.7 Emulsions              
 7.8 Carbohydrates Adjuvants            
 7.9 Bacteria-derived Adjuvants     
 7.10 Other Types    
      
8 Global Vaccine Adjuvants Market, By Mechanism of action     
 8.1 Introduction    
 8.2 Vehicle Adjuvants     
 8.3 Carriers         
 8.4 Active Immunostimulants    
      
9 Global Vaccine Adjuvants Market, By Route of Administration     
 9.1 Introduction    
 9.2 Subcutaneous Route     
 9.3 Oral Route     
 9.4 Intranasal Route     
 9.5 Intramuscular Route     
 9.6 Intradermal Route     
 9.7 Other Route of Administrations    
      
10 Global Vaccine Adjuvants Market, By Application     
 10.1 Introduction    
 10.2 Veterinary Vaccine Adjuvants    
 10.3 Human Vaccine Adjuvants     
      
11 Global Vaccine Adjuvants Market, By End User     
 11.1 Introduction    
 11.2 Research Institutes    
 11.3 Pharmaceutical Companies    
 11.4 Contract Manufacturing Organization    
 11.5 Commercial     
 11.6 Pediatric    
 11.7 Adults    
 11.8 Other End Users    
      
12 Global Vaccine Adjuvants Market, By Geography     
 12.1 Introduction    
 12.2 North America    
  12.2.1 US   
  12.2.2 Canada   
  12.2.3 Mexico   
 12.3 Europe    
  12.3.1 Germany   
  12.3.2 UK   
  12.3.3 Italy   
  12.3.4 France   
  12.3.5 Spain   
  12.3.6 Rest of Europe   
 12.4 Asia Pacific    
  12.4.1 Japan   
  12.4.2 China   
  12.4.3 India   
  12.4.4 Australia   
  12.4.5 New Zealand   
  12.4.6 South Korea   
  12.4.7 Rest of Asia Pacific   
 12.5 South America    
  12.5.1 Argentina   
  12.5.2 Brazil   
  12.5.3 Chile   
  12.5.4 Rest of South America   
 12.6 Middle East & Africa    
  12.6.1 Saudi Arabia   
  12.6.2 UAE   
  12.6.3 Qatar   
  12.6.4 South Africa   
  12.6.5 Rest of Middle East & Africa   
      
13 Key Developments     
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 13.2 Acquisitions & Mergers    
 13.3 New Product Launch    
 13.4 Expansions    
 13.5 Other Key Strategies    
      
14 Company Profiling     
 14.1 Viscogel AB    
 14.2 Vaxliant    
 14.3 Vaxine Pty Ltd.    
 14.4 Sigma Aldrich (Merck KGaA)    
 14.5 Sergeant Adjuvants    
 14.6 OZ Biosciences    
 14.7 Novavax, Inc.    
 14.8 Novartis/CSL    
 14.9 MVP Laboratories, Inc.    
 14.10 Kineta, Inc.    
 14.11 Invivogen    
 14.12 GSK    
 14.13 CureVac AG    
 14.14 CSL Limited    
 14.15 Avanti Polar Lipids    
 14.16 Aphios Corp.    
 14.17 Agenus, Inc.    
 14.18 Adjuvatis    
 14.19 Adjuvance Technologies, Inc    


List of Tables      
1 Global Vaccine Adjuvants Market Outlook, By Region (2016-2026) (US $MN)      
2 Global Vaccine Adjuvants Market Outlook, By Product (2016-2026) (US $MN)     
3 Global Vaccine Adjuvants Market Outlook, By Pathogen Components (2016-2026) (US $MN)     
4 Global Vaccine Adjuvants Market Outlook, By Particulate Adjuvants (2016-2026) (US $MN)     
5 Global Vaccine Adjuvants Market Outlook, By Combination Adjuvants (2016-2026) (US $MN)     
6 Global Vaccine Adjuvants Market Outlook, By Adjuvant Emulsions (2016-2026) (US $MN)     
7 Global Vaccine Adjuvants Market Outlook, By Saponin (2016-2026) (US $MN)     
8 Global Vaccine Adjuvants Market Outlook, By Other Types (2016-2026) (US $MN)     
9 Global Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) (US $MN)     
10 Global Vaccine Adjuvants Market Outlook, By Cancer (2016-2026) (US $MN)     
11 Global Vaccine Adjuvants Market Outlook, By Infectious Diseases (2016-2026) (US $MN)     
12 Global Vaccine Adjuvants Market Outlook, By Other Disease Types (2016-2026) (US $MN)     
13 Global Vaccine Adjuvants Market Outlook, By Type (2016-2026) (US $MN)     
14 Global Vaccine Adjuvants Market Outlook, By Virus-like Particles (2016-2026) (US $MN)     
15 Global Vaccine Adjuvants Market Outlook, By Tensoactive Adjuvants (2016-2026) (US $MN)     
16 Global Vaccine Adjuvants Market Outlook, By Organic Adjuvants (2016-2026) (US $MN)     
17 Global Vaccine Adjuvants Market Outlook, By Mineral Salt based Adjuvants (2016-2026) (US $MN)     
18 Global Vaccine Adjuvants Market Outlook, By Liposomes (2016-2026) (US $MN)     
19 Global Vaccine Adjuvants Market Outlook, By Emulsions (2016-2026) (US $MN)     
20 Global Vaccine Adjuvants Market Outlook, By Carbohydrates Adjuvants (2016-2026) (US $MN)     
21 Global Vaccine Adjuvants Market Outlook, By Bacteria-derived Adjuvants (2016-2026) (US $MN)     
22 Global Vaccine Adjuvants Market Outlook, By Other Types (2016-2026) (US $MN)     
23 Global Vaccine Adjuvants Market Outlook, By Mechanism of action (2016-2026) (US $MN)     
24 Global Vaccine Adjuvants Market Outlook, By Vehicle Adjuvants (2016-2026) (US $MN)     
25 Global Vaccine Adjuvants Market Outlook, By Carriers (2016-2026) (US $MN)     
26 Global Vaccine Adjuvants Market Outlook, By Active Immunostimulants (2016-2026) (US $MN)     
27 Global Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) (US $MN)     
28 Global Vaccine Adjuvants Market Outlook, By Subcutaneous Route (2016-2026) (US $MN)     
29 Global Vaccine Adjuvants Market Outlook, By Oral Route (2016-2026) (US $MN)     
30 Global Vaccine Adjuvants Market Outlook, By Intranasal Route (2016-2026) (US $MN)     
31 Global Vaccine Adjuvants Market Outlook, By Intramuscular Route (2016-2026) (US $MN)     
32 Global Vaccine Adjuvants Market Outlook, By Intradermal Route (2016-2026) (US $MN)     
33 Global Vaccine Adjuvants Market Outlook, By Other Route of Administrations (2016-2026) (US $MN)     
34 Global Vaccine Adjuvants Market Outlook, By Application (2016-2026) (US $MN)     
35 Global Vaccine Adjuvants Market Outlook, By Veterinary Vaccine Adjuvants (2016-2026) (US $MN)     
36 Global Vaccine Adjuvants Market Outlook, By Human Vaccine Adjuvants (2016-2026) (US $MN)     
37 Global Vaccine Adjuvants Market Outlook, By End User (2016-2026) (US $MN)     
38 Global Vaccine Adjuvants Market Outlook, By Research Institutes (2016-2026) (US $MN)     
39 Global Vaccine Adjuvants Market Outlook, By Pharmaceutical Companies (2016-2026) (US $MN)     
40 Global Vaccine Adjuvants Market Outlook, By Contract Manufacturing Organization (2016-2026) (US $MN)     
41 Global Vaccine Adjuvants Market Outlook, By Commercial (2016-2026) (US $MN)     
42 Global Vaccine Adjuvants Market Outlook, By Pediatric (2016-2026) (US $MN)     
43 Global Vaccine Adjuvants Market Outlook, By Adults (2016-2026) (US $MN)     
44 Global Vaccine Adjuvants Market Outlook, By Other End Users (2016-2026) (US $MN)     
      
NOTE:  Tables for North America, Europe, Asia Pacific, South America, and Middle East & Africa are represented in the same manner above.     

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials